Dr. Bruce D. Klugherz, MD

Dr. Klugherz practices at AMS Cardiology in Horsham, Pennsylvania.

Dr. Klugherz's NPI, 1417941915, was assigned on September 12, 2005. Dr. Klugherz graduated from Duke University School of Medicine in 1992. Dr. Klugherz holds Pennsylvania license MD-054265L.

Dr. Klugherz's primary practice is AMS Cardiology, at 118 Welsh Rd, Horsham, PA 19044 in Montgomery County. The practice phone is (215) 517-1000.

Dr. Klugherz's primary practice is AMS Cardiology in Horsham, Pennsylvania. Dr. Klugherz is also affiliated with Thomas Jefferson University Hospital. The medical group on file is AMS Cardiology. Dmand AI also links Dr. Klugherz to 4 more hospitals, 7 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klugherz practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Klugherz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Klugherz is licensed in Pennsylvania.

CMS data shows 7,989 Medicare services from Dr. Klugherz across 43 procedure codes in 2024, for 1,526 Medicare patients. Medicare paid $625,841 for them.

CMS counts 1,526 Medicare patients who saw Dr. Klugherz in 2024. The largest group is 75 to 84, with 675 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Klugherz's median patient age at 74, with 45% women.

In 2024, Dr. Klugherz wrote 10,337 Medicare Part D claims for 1,172 patients. 84% of them were for generic drugs. CMS names the drug for 9,985 of them, across 83 drugs with 11 or more claims each, at $2,796,442 in total drug cost. In 2023, CMS named 9,202 claims across 78 drugs.

Dr. Klugherz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Klugherz as offering telehealth. CMS counts 74 procedures of coronary angioplasty and stenting by Dr. Klugherz, more than 92% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Klugherz, published from 2014 to 2025. The most frequent topics are Hemorrhage and Randomized Controlled Trials as Topic. Dr. Klugherz has published most often in J Investig Med High Impact Case Rep. Dr. Klugherz's most frequent co-authors are Ali Raza Ghani, MD, Reema Anjum, MD and Charles D. Gottlieb, MD.

CMS Open Payments shows 1,362 general payments to Dr. Klugherz from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Janssen Pharmaceuticals, Inc paid the most, $66,782. It also lists 2 research payments totaling $59,637 from 2016 to 2024, naming 1 clinical trial.

Dr. Klugherz graduated from Duke University School of Medicine in 1992.